The Artificial Joint Market continues to grow at a CAGR of 5–6%, driven by the rising prevalence of musculoskeletal disorders and an aging population. Current estimates place the market at $22–25 billion, with projections reaching $33–43 billion by 2030–2032. Hip and knee replacements dominate in both value and procedure volume, while shoulder and elbow procedures are gradually expanding.

This size reflects both demand in established regions and rising interest in emerging markets. Increasing life expectancy, active lifestyles among older adults, and demand for minimally invasive surgeries further support market expansion. Hospitals remain the largest end-users, though outpatient clinics and specialty centers are becoming important contributors to growth.

FAQ:
Q1: How big is the current market?
A1: Around $22–25 billion globally.
Q2: What is the projected size by 2030?
A2: Between $33 and $43 billion.